PHC Holdings
VC Fund
Tokyo, Japan
PHC Holdings is a VC fund in Tokyo focused on Health Care and Medical. Panasonic Healthcare is a global corporation focused on the development of healthcare and research technology. Known throughout the world as a leader in consumer electronics and appliances, Panasonic addresses global needs, such as energy, food, housing, health, and information technology. Here at Panasonic Healthcare, we combine ideas andinnovations from our worldwide network of industrial and consumer products into a complete line of biomedical products.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries PHC Holdings invests in
Stages PHC Holdings invests in
Countries PHC Holdings invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Hidehito Kotani
|
|||
Hiroaki Kondo
|
|||
Kenji Yamane
|
|||
Koichiro Sato
|
|||
|
Masatsugu Miyazaki
|
|||
| See all 10 contacts → | |||
Investment Focus
Industry
- Health Care 3 (50%)
- Medical 2 (33%)
- Biotechnology 2 (33%)
- Medical Device 2 (33%)
- Sensor 1 (17%)
Stage
- Series B 1 (17%)
- Series C 1 (17%)
- Series D 1 (17%)
- Post-IPO Debt 1 (17%)
- Post-IPO Equity 1 (17%)
Country
- Finland 1 (17%)
- Switzerland 1 (17%)
- United States 1 (17%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Hidehito Kotani
President & CEO & CTO; Director
|
President & CEO & CTO; Director | Total investments: 0 | Find email | |
|
Hiroaki Kondo
Representative Director & Senior Corporate Executive Officer & COO
|
Representative Director & Senior Corporate Executive Officer & COO | Total investments: 0 | Find email | |
|
Kenji Yamane
Chairman
|
Chairman | Total investments: 0 | Find email | |
|
Koichiro Sato
COO
|
COO | Total investments: 0 | Find email | |
|
Masatsugu Miyazaki
Vice President & COO
|
Vice President & COO | Total investments: 0 | Find email | |
| See all 10 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Lunaphore
|
Lunaphore Technologies S.A. is a Swiss company born with the vision of accelerating cancer research by bringing the field of spatial biology into mainstream laboratories. Lunaphore has developed its innovative spatial biology solutions based on an award-winning technology called FFeX (Fast Fluidic Exchange). Lunaphore has been recognized as one ofthe most innovative companies internationally. | $32.7M / Series D / Mar 23, 2023 | |
|
Lunaphore
|
Lunaphore Technologies S.A. is a Swiss company born with the vision of accelerating cancer research by bringing the field of spatial biology into mainstream laboratories. Lunaphore has developed its innovative spatial biology solutions based on an award-winning technology called FFeX (Fast Fluidic Exchange). Lunaphore has been recognized as one ofthe most innovative companies internationally. | $12M / Convertible Note / Aug 01, 2021 | |
Aiforia
|
Aiforia Technologies was founded as a spin-off company from the Finnish Institute for Molecular Medicine (FIMM) at the University of Helsinki in 2013 by researchers and pioneers in the field of cloud-based microscopy and pathology and experienced life science entrepreneurs. The Aiforia® Platform brings together deep learning AI and high-performancecloud computing. Aiforia assists with the increased demand for image-based diagnostics by providing efficient and scalable solutions – enabling new discoveries and clinical support with highly accurate and consistent data. Aiforia is technologically driven establishment and keeps the capability of being image agnostic thus extending its solutions to multiple fields. | $15.3M / Series B / Jun 08, 2021 | |
Senseonics
|
Senseonics is a medical device startup company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products that is intended to enable people with diabetes to confidently live their lives with ease. Utilizing breakthrough fluorescence sensing technology, the Senseonics continuous glucose monitoring("CGM") system is being designed to be the first fully implantable CGM that is highly accurate and stable throughout its long sensor life. | $45M / Post-IPO Equity / Aug 10, 2020 | |
|
Senseonics
|
Senseonics is a medical device startup company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products that is intended to enable people with diabetes to confidently live their lives with ease. Utilizing breakthrough fluorescence sensing technology, the Senseonics continuous glucose monitoring("CGM") system is being designed to be the first fully implantable CGM that is highly accurate and stable throughout its long sensor life. | $35M / Post-IPO Debt / Aug 10, 2020 | |
|
Lunaphore
|
Lunaphore Technologies S.A. is a Swiss company born with the vision of accelerating cancer research by bringing the field of spatial biology into mainstream laboratories. Lunaphore has developed its innovative spatial biology solutions based on an award-winning technology called FFeX (Fast Fluidic Exchange). Lunaphore has been recognized as one ofthe most innovative companies internationally. | $23.6M / Series C / Feb 06, 2020 |
Co-Investors
OCCIDENT
3 deals together
Alpana Ventures
2 deals together
redalpine
2 deals together
Ernst Gohner Stiftung
1 deal together
Masters Capital Management
1 deal together
Swiss Entrepreneurs Fund
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does PHC Holdings invest in?
PHC Holdings invests primarily in Health Care, Medical and Biotechnology startups, most often at Series B and Series C stage. Most of the 6 investments tracked by Shizune back companies in Finland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact PHC Holdings?
Public channels for PHC Holdings include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at PHC Holdings?
The team at PHC Holdings includes Hidehito Kotani (President & CEO & CTO; Director), Hiroaki Kondo (Representative Director & Senior Corporate Executive Officer & COO) and Kenji Yamane (Chairman), among 10 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
